{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-027467","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2021-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.101423+00:00","generated_at":"2026-06-28T05:02:46.414295+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"2021 annual meeting results: directors elected, executive compensation approved, auditor ratified","bullets":["E Gerald Kay, Riva Sheppard, and Carl DeSantis elected as Class I directors until 2024 annual meeting.","Non-binding advisory vote on executive compensation approved with 20.2M for, 0.7M against, 2.1M abstain.","Ratification of Friedman LLP as independent auditor for FY ending June 30, 2022 approved (23.8M for, 6.4K against).","Total shares voted: 24.1M out of 29.8M eligible (quorum present)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-027467","json":"https://secwatch.observer/filing/0001437749-21-027467.json","markdown":"https://secwatch.observer/filing/0001437749-21-027467.md","text":"https://secwatch.observer/filing/0001437749-21-027467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774921027467/0001437749-21-027467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774921027467/inbp20211129_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:02:46.414295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}